The testing project is proving to be a national model, because of the challenges the organizers overcame and what it showed about the spread of Covid-19. More
Some communities considered community antibody testing as a way out of lockdown. But they’ve pulled back as they realized antibody testing is the Wild West in an oversight vacuum. More
Producers looking to meet “unprecedented” demand were told they could sell tests as long as they validated them internally and filed for FDA emergency use authorization within 15 days. Shortly after came complaints of scams and unreliable tests. More
Perspective from The New England Journal of Medicine — Covid-19 — A Reminder to Reason More
A new poll finds nearly half of Americans are suffering mental health problems due to a loss of income or job and missing medical care, with women suffering more than men. More
Across Texas, a growing number of poor, unemployed or unsuspecting patients are being sued for uncollected medical debt in a trend that some see as predatory. More
New details emerge in a lawsuit asserting that chains including CVS, Rite Aid and Walgreens sold millions of pills in small towns but rarely flagged suspicious orders to authorities. More
An NPR investigation shows that black and Latino neighborhoods in four large Texas cities have fewer coronavirus testing sites, leaving communities blind to potential COVID-19 outbreaks. More
Covid-19 makes it difficult to practice evidence-based medicine and just as hard to make decisions about the small questions that dictate day-to-day life. More
H. Gilbert Welch and Vinay Prasad write that since the pandemic forced the medical care system to cancel elective surgeries and have fewer outpatient visits, Covid-19 provides a once in a lifetime opportunity to study if some, who are not acutely ill, do better with less medical care. More
Like so many other aspects of our health care system, the pandemic has laid bare the flaws in our electronic health record system. More
Critics say the government deserves more credit for tens of millions in public money spent to develop the coronavirus treatment. More
Local governments struggle to offer isolation options, testing and Spanish-language help to hard-hit Latino neighborhoods. More
But an important caveat: exam quality matters More
This Viewpoint discusses the importance of carefully evaluating SARS-CoV-2 vaccine candidates for safety and efficacy in the context of political pressure to accelerate the process, widespread vaccine hesitancy and refusal, and distrust of science. More
During this unprecedented health crisis, what will it take for hospitals to put aside their rivalries and work together? Shannon Brownlee and Vikas Saini discuss in the latest edition of "Lown Hospitals Q&A." More
Twenty large chains received more than $5 billion in federal grants even while sitting on more than $100 billion in cash. More
A dad in Denver tried to do everything right when COVID symptoms surfaced. Still, he ended up with a huge bill from an insurer that had said it waived cost sharing for coronavirus treatment. More
New research points to an issue AI researchers are increasingly worried about: Training systems on data skewed by sex could make them less accurate. More
As coronavirus health concerns, social isolation and job-loss stress take a toll, people turn to medications; “It can very quickly become a habit.” More